LJPC-401

· La Jolla Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LJPC-401, covering 2022-06-09 to 2022-06-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis [Phase 2]

See pricing